To determine the cellular and molecular mechanisms by which acid-sensing ion channel 1a (ASIC1a) plays its role in the secondary injury after traumatic spinal cord injury (SCI), and validate the neuroprotective effect of ASIC1a suppression in SCI model in vivo. Background: Secondary damage after traumatic SCI contributes to the exacerbation of cellular insult and thereby contributes to spinal cord dysfunction. However, the underlying mechanisms remain largely unknown. Acidosis is commonly involved in the secondary injury process after the injury of central nervous system, but whether ASIC1a is involved in secondary injury after SCI is unclear. Methods: Male Sprague-Dawley rats were subjected to spinal contusion using a weight-drop injury approach. Western blotting and immunofluorescence assays were used to observe the change of ASIC1a expression after SCI. The TUNEL staining in vivo as well as the cell viability and death assays in spinal neuronal culture were employed to assess the role of ASIC1a in the secondary spinal neuronal injury. The electrophysiological recording and Ca 2 + imaging were performed to reveal the possible underlying mechanism. The antagonists and antisense oligonucleotide for ASIC1a, lesion volume assessment assay and behavior test were used to estimate the therapeutic effect of ASIC1a on SCI. Results: We show that ASIC1a expression is markedly increased in the periinjury zone after traumatic SCI. Consistent with the change of ASIC1a expression in injured spinal neurons, both ASIC1a-mediated whole-cell currents and ASIC1a-mediated Ca 2 + entry are significantly enhanced after injury. We also show that increased activity of ASIC1a contributes to SCI-induced neuronal death. Importantly, our results indicate that down-regulation of ASIC1a by antagonists or antisense oligonucleotide reduces tissue damage and promotes the recovery of neurological function after SCI. Conclusion: This study reveals a cellular and molecular mechanism by which ASIC1a is involved in the secondary damage process after traumatic SCI. Our results suggest that blockade of Ca 2 + -permeable ASIC1a may be a potential neuroprotection strategy for the treatment of SCI patients. (Ann Surg 2011;254:353-362) Male Sprague-Dawley rats (∼220 grams) were housed on a 12 hour light/dark cycle with standard rat chow and water ad libitum. Each animal was anesthetized with sodium pentobarbital (50 mg/kg i.p.), and a laminectomy was performed at T9 to expose a circle of dura. Spinal contusion injury was produced using the weight-drop injury model. 30,31 A 10 grams weight rod with diameter of 2.5 mm was dropped from a height of 10 mm onto the exposed rat spinal
T he extent of secondary injury initiated by the primary trauma determines the outcome of spinal cord injury (SCI). [1] [2] [3] [4] However, the cellular and molecular mechanisms by which the second damage contributes to SCI remain unclear. Although increased evidence suggests that the secondary injury process involves ischemia, excitotoxicity, inflammation, oxidant stress, energy failure and other cellular and molecular events, 5, 6 no therapeutic strategy targeting on the secondary injury mechanisms has been developed for the treatment of SCI patients.
Acidosis is commonly involved in the secondary injury process in the injury of central nervous system (CNS), including SCI. [7] [8] [9] Acidosis after SCI may be mediated by the following secondary injury mechanisms: (1) ischemia causes energy failure and leads to accumulation of lactate and substantial accumulation of H + at the lesion site and circumference 8,10-13 ; (2) SCI-induced large release of glutamate and ATP causes excitotoxicity, which contributes to H + production and acidosis [14] [15] [16] ; (3) inflammation in injured spinal cord induces local acidosis. 17, 18 Therefore, acidosis is a critical factor influencing the pathophysiological process of SCI.
Recent study reveals that the acid-sensing ion channels (ASICs) mediate acidosis-induced effects in pathological conditions. 17, 19, 20 ASICs are members of the epithelial Na + channel/degenerin (ENaC/DEG) superfamily of nonvoltage-gated cation channels. 21, 22 ASICs are widely distributed in the central and peripheral nervous system. Four ASIC genes (ASIC1 to ASIC4) and 7 ASIC subunits have been identified: 1a, 1b, 1b2, 2a, 2b, 3, and 4. ASICs have been implicated in synaptic plasticity, learning and memory, pain perception, taste transduction, and the mechanoreception. 21, [23] [24] [25] In ischemic/hypoxic conditions, ASICs, especially ASIC1a, are involved in acidosis-mediated, glutamate-independent, neuronal injury through Ca 2 + influx. 19, 26 ASIC1a has been found to be the main ASIC subtype distributing in the spinal cord, 27, 29 but its role in SCI is unknown. Because tissue acidosis occurs after SCI, it is possible that local acidosis will lead to increased activation of ASICs, especially Ca 2 + -permeable ASIC1a channels, and thereby extend the local injury. To test this hypothesis, we employed a weight-drop contusive model 30, 31 and investigated the role of ASIC1a in delayed spinal cell death as well as functional recovery after SCI. Our study suggests that upregulation of Ca 2 + -permeable ASIC1a underlies secondary damage after SCI. This finding also underscores the importance that ASIC1a is a potential therapeutic target for the development of new neuroprotective agents for SCI patients.
cord. For sham surgery, animals were age-, sex-, and weight-matched undergoing laminectomy without contusion. Body temperatures were maintained at 37 • C on a heating pad throughout the procedure. Bladders were manually expressed twice daily until reflex bladder emptying returned. All experiments were carried out in accordance with China Animal Welfare Legislation and were approved by the Institutional Animal Care and Use Committee of Institute of Neuroscience, Shanghai, China.
Gel Electrophoresis and Immunoblotting
Spinal cords were quickly removed after animals were anesthetized. Samples of cord (12 mm) were taken from the thoracic level (including the epicenter of injury, 4 mm in length) as well as areas rostral (4 mm) and caudal (4 mm) to the injury site. Immunoblotting procedures were performed as previously described. 27 In briefy, samples were homogenized and then centrifuged at 13,000 rpm for 15 minutes at 4 • C, and the supernatants were boiled for 5 minutes and separated using SDS-PAGE gel containing 7.5% polyacrylamide and transferred to polyvinylidene difluoride (PVDF) membranes (Healthcare, Buckinghamshire, UK). The membranes were blocked with 5% nonfat milk in TBST (20 mM Tris-HCl, pH 7.4, 140 mM NaCl, and 0.1% Tween-20) at room temperature for 1 hour, and then incubated at 4 • C overnight with anti-ASIC1a (1:200; Alomone Labs, Jerusalem, Israel), or anti-β-tubulin (1:1000; KangChen, Shanghai, China) antibodies followed by the appropriate secondary antibodies conjugated with horseradish peroxidase. Washes were performed with TBST. The immunoreactivity was detected using enhanced chemiluminescence (ECL; GE Healthcare). The ECL-exposed films were digitized, and densitometric quantification of immunoreactive bands was performed using ImageJ (Wayne Rasband, National Institutes of Health, Bethesda, MD, http://rsb.info.nih.gov/ij).
Immunohistochemistry
Experimental rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and perfused with 4% paraformaldehyde in phosphate buffer (0.1 M, pH 7.4). The spinal cord (12 mm, centered at the injury epicenter, including areas rostral and caudal to the epicenter) was removed and cryoprotected overnight in a 30% sucrose solution at 4 • C. Longitudinal and transverse frozen sections (30 μm thick) were cut with a cryostat (Leica CM1900, Leica, Wetzlar, Germany) at − 20 • C from different sample cords, respectively (at least 3 animals for each group). Double immunofluorescent staining was performed on parallel sections with antibodies against ASIC1a (1:200; Millipore, Temecula, CA), NeuN (1:200; Millipore). Secondary antibodies included goat anti-rabbit FITC and anti-mouse Rhodamine (1:70; Rockland, Gilbertsville, PA). Slides were observed and photographed using a 2-photon confocal microscope (Zeiss LSM510, Oberkochen, Germany). Image analysis was performed as previously described. 27
Lesion Volume Assessment
The volume of lesion tissue of injured spinal cord was analyzed as reported previously with some modification. 32, 33 Briefly, digital images of every fifth transverse section (30 μm thick) of 12mm-length spinal cord centered at the lesion epicenter was collected (n = 5 per group). Lesion zone was identified as gross areas of cellular breakdown, debris and tissue fragmentation. Volume quantification was assessed using unbiased stereology and the Stereologer Program (Systems Planning and Analysis, Alexandria, VA). Two different blinded individuals quantitated these lesions, and their scores were averaged.
Primary Culture of Spinal Cord Neurons
The cultures were prepared as reported previously with some modification. [34] [35] [36] In brief, spinal cords of rats were dissociated in Ca 2 + -free saline with sucrose (20 mM). After removal of the meninges and dorsal root ganglia, spinal cords were minced into 1mm 3 fragments and placed into DMEM containing 0.25% trypsin (Difco, 1:250, Detroit, MI) and 0.01% DNase for 15 minutes at 37 • C. After gentle centrifugation (190g, 5 minutes), the supernatant was discarded and the tissue pellet was suspended in serum-containing basal media and triturated through a flame-polished, fine-bore Pasteur pipette. Cells were centrifuged (190g, 3 minutes) and resuspended in fresh growth media and plated (1-2 × 10 5 cell/mL) on poly-D-lysine (Sigma)-coated cover glasses. The neurons were grown in Dulbecco's modified Eagle's medium with L-glutamine plus 10% fetal bovine serum and 10% F-12 nutrient mixture (Invitrogen). After 1 day, Neurobasal medium (1.5 ml, Invitrogen) with 2% B27 (Invitrogen) was replaced every 3 to 4 days. Treatment with 5-fluoro-2'deoxyuridine (20 μg/mL, Sigma) on the 4th day after plating was used to block cell division of nonneuronal cells, which helped to stabilize the cell population. The cultures were maintained at 37 • C in a 5% CO 2 -humidified atmosphere. Neurons were used for patch-clamp recording and Ca 2 + imaging 9 to 14 days after plating.
Electrophysiology
The electrophysiological recordings were performed in the conventional whole-cell patch-clamp recording configuration under voltage clamp conditions. Patch pipettes were pulled from glass capillaries with an outer diameter of 1.5 mm (Narishige, Tokyo, Japan) on a 2-stage puller (PP-830, Narishige Co. Ltd., Tokyo, Japan). The resistance between the recording electrode filled with pipette solution and the reference electrode was 4 to 6 M . Patch pipettes were filled with the following solution (in mM): 120 KCl, 30 NaCl, 0.5 CaCl 2 , 1 MgCl 2 , 5 EGTA, 2 MgATP, and 10 HEPES, pH 7.2. The standard extracellular solution contained (in mM) 150 NaCl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , and 10 glucose, buffered to various pH values with 10 mM HEPES, pH 6.0 to 7.4. Membrane currents were measured using a patch clamp amplifier (Axopatch 200B, Axon Instruments, Foster City, CA), filtered at 1 kHz, sampled, and analyzed using a DigiData 1320A interface and a computer with the pCLAMP system (Version 8.0, Axon Instruments, Foster City, CA). The series resistance, estimated from optical cancellation of the capacity transient, was 10 to 30 M , and in most experiments, 70% to 90% series resistance was compensated. The membrane potential was voltage clamped at -60 mV throughout the experiments under voltage clamp conditions. All experiments were carried out at room temperature (22-25 • C). All drugs for electrophysiological experiments were purchased from Sigma except for psalmotoxin 1 (PcTx1 venom), which was obtained as the venom of the South American tarantura Psalmopoeus cambridgei. 37
Ca 2 + Imaging
According to the previously described methods, 26, 27 intracellular Ca 2 + imaging was carried out as follows. Primary cultured spinal neurons grown on 8 × 8 mm glass coverslips were washed 3 times with PBS and then incubated with 1 μM Fura-2-acetoxymethyl ester for 20 minutes at 37 • C, they were again washed 3 times and incubated in standard extracellular solution for 30 minutes. Then, coverslips were transferred to a perfusion chamber on an inverted microscope (Nikon TE2000-E, Tokyo, Japan). Experiments were performed by using a 40 × UV fluor oil-immersion objective lens, and images were recorded by a cooled CCD camera (Hamamatsu Photonics, Hamamatsu City, Japan). To block potential Ca 2 + entry through voltage-gated Ca 2 + channels or glutamate receptors, 10 μM nifedipine, 20 μM APV and 10 μM CNQX were added to the bath solution. The fluorescence excitation source was a 75-Watt xenon arc lamp. The fluorescence-ratio images were acquired by using alternating excitation wavelengths (340/380 nm) with a monochromator (Polychrome IV; Till, Munich, Germany). Fura-2 fluorescence was detected at emission wavelength of 510 nm. Digitized images were acquired and analyzed in a personal computer controlled by Sim-plePCI (Compix, Sewickley, PA). Ratio images (340/380 nm) were analyzed by averaging pixel ratio values in circumscribed regions of cells in the field of view. The data were exported and further analyzed by Origin 7.0.
TUNEL Staining
The TUNEL (TdT-mediated dUTP-X nick end labeling) assay was conducted by using a TUNEL detection kit according to the manufacturer's instructions (In Situ Cell Death Detection Kit, TMR red, Roche, Switzerland).
Cell Viability and Death Assays with FDA and PI Staining
The assays were performed according to the methods previously described with some modification. 19, 26 In brief, cultures were rinsed with PBS and incubated with fluorescein diacetate (FDA, 5 μM) and propidium iodide (PI, 2 μM) for 30 minutes, and then rinsed with PBS. Alive (FDA-positive) and dead (PI-positive) cells were viewed and counted on a microscope (Zeiss) equipped with epifluorescence at 580/630 nm excitation/emission for PI and 500/550 nm for FDA. For each slide, 15 random fields were enumerated.
Intrathecal Administration of Antisense
For intrathecal delivery of drugs, We performed as previous description. 27 The 18-mer antisense oligonucleotide (AS) was designed in the 5' part of the coding sequence as previously reported (5'-GTG CCC GCT TCA GAG ACA-3'), and the inverted sequence (IS) was used as a control (5'-ACA GAG ACT TCG CCC GTG-3'). 27, 38 Intrathecal treatment with both AS and IS was used at 45 μg in 10 μL of saline per rat, twice daily for 4 days. Then, the rats were subjected to spinal cord injury. Intrathecal treatment with 10 μL of saline was used as vehicle control.
Behavioral Test
Animals were assigned to treatment groups blindly and functional deficits were measured in a blinded manner. Locomotor function was observed every 3 days after SCI and recorded using the Basso, Beattie, and Bresnahan (BBB) Locomotor Rating Scale. 39
Data Analysis
Results were expressed as mean ± SE. Statistical comparisons were performed using paired or unpaired Student's t tests or 1-way ANOVA. Statistical significance was placed at P < 0.05.
RESULTS

ASIC1a Expression is Increased in Injured Spinal Cord
To determine the role of ASIC1a in SCI, we first examined ASIC1a expression in injured cord using the weight-drop SCI model. 30, 31 We performed immunoblotting and immunohistochemical assays to measure the protein expression of ASIC1a in 2 injury regions: injury site (4 mm in length, including injury epicenter) and peri-injury site (4 mm in length, rostral and caudal to injury site, respectively). At peri-injury site (indicated as "P" in Fig. 1A) , Western blot analysis showed that ASIC1a expression was markedly increased 3 hours after injury and reached its peak during 12-24 hours, and weeks after SCI. At peri-injury site, ASIC1a level increased at 3 hours after injury, reached its peak at 12 to 24 hours, and started to decrease at 24 hours postinjury, and fell to control level 1 week after injury. In contrast, the expression of ASIC1a at the injury site was decreased at 3 hours after SCI, and fell to lower level at 1 week postinjury without recovery. β-Tubulin was used as the loading control. All the samples from different time points were uploaded in 2 gels, both then were run, transferred, immunoblotted and detected in the same way at the same time. B and C, Summarized data showing the normalized ASIC1a levels at peri-injury site (B) and injury site (C). The relative levels of ASIC1a protein expression were quantified by densitometry from experiments shown in (A). Data (mean ± SE) were normalized to the mean value from 3 rats in the corresponding "Contl" groups. *P < 0.05, **P < 0.01, compared with "Contl" (1-way ANOVA).
started to fall 24 hours after injury. ASIC1a expression was recovered to the control level 1 week after injury, and remained for up to 6 weeks ( Fig. 1A and B ). Unlike the peri-injury site, ASIC1a expression at the injury site (indicated as "I" in Fig. 1A ) was significantly decreased at 3 hours after SCI, and the expression level continued to fall without recovery ( Fig. 1A and C) .
To locate the change of ASIC1a expression after SCI, we performed immunocytochemical labeling of ASIC1a in longitudinal and transverse sections of spinal cords. Our results showed that ASIC1a expression was significantly increased in the peri-injury site after insult ( Fig. 2A1 and B1 ). Statistic analysis showed that ASIC1a expression was increased at 12 hour after SCI ( Fig. 2A2 and B2 ). Although ASIC1a was detectable at the injury site, ASIC1a-positive cells were dramatically decreased due to loss of cells caused by primary injury, 1, 40 which may explain why western blotting data showed decreased ASIC1a level at the injury site after SCI. The specificity of ASIC1a antibody used in this study was tested (see Supplemental Digital Content 1, available at: http://links.lww.com/SLA/A142). 
ASIC1a Activity is Enhanced in Spinal Neurons by Hypoxia
To first test whether the increased expression of ASIC1a led to a functional consequence. We recorded ASIC1a-mediated whole-cell currents in cultured spinal neurons at 9 to14 day in vitro (DIV). At a holding potential of -60 mV, acidic stimulation at pH 6.0 evoked large transient inward currents (I 6.0 , Fig. 3A1 ). Consistent with the evidence that ASIC1a is the dominant ASIC distributed in rat spinal dorsal horn, 27,28 specific ASIC1a antagonist psalmotoxin 1 (PcTx1 venom, 5 μg/mL) or nonspecific ASIC antagonist amiloride (100 μM) were found to inhibit I 6.0 in cultured spinal neurons ( Fig. 3A1-A3 ). These data also indicate that the acid-induced currents in cultured spinal neurons are mediated by ASIC1a.
We next examined whether ASIC1a-mediated currents was increased through secondary injury mechanisms. Because ischemia/hypoxia is critically involved in the secondary injury process after SCI, 3, 10, 11 we set up to record ASIC1a-mediated currents in cultured spinal neurons treated with sodium cyanide (NaCN, 10 − 4 M), an agent widely used in the study of hypoxic insult. 26 , 41,42 We showed that the peak amplitude of I 6.0 was not altered during repeated applications of the same acidic solution. However, after 5 minutes of NaCN treatment, the amplitude of I 6.0 was markedly increased ( Fig. 3B1 and B3 ). The current amplitude was returned to control level after washout of NaCN (data not shown). We further showed that KN93 (5 μM), an inhibitor of calcium/calmodulin-dependent kinase II (CaMKII), prevented NaCN-induced enhancement of ASIC1a currents, suggesting that regulation of ASIC1a by CaMKII may mediate NaCN-induced enhancement of ASIC1a currents ( Fig. 3B2 and  B3 ). This is consistent with previous finding that NaCN enhanced ASIC1a currents through CaMKII phosphorylation of the channels in hippocampal neurons. 26 The homomeric ASIC1a channels are permeable to Ca 2 + . 19, 20, 26 To provide further evidence to support the enhancement of ASIC1a function by NaCN-induced hypoxic insult, we tested whether intracellular Ca 2 + concentration ([Ca 2 + ] i ) is altered in spinal neurons in response to acidic solution (pH 6.0) using Fura-2
Increased Activity of ASIC1a Promotes Spinal Cell Death
To investigate whether ASIC1a is involved in mediating SCIinduced cell death, we performed TUNEL staining to analyze the apoptotic cell death in the injured spinal cord. As shown in Fig. 5A1 , in the peri-injury site 39.5% of TUNEL-positive cells are ASIC1apositive and 48.8% ASIC1a-positive cells are TUNEL-positive. As a control, ASIC2a-labelled cells were not TUNEL-positive (data not shown). Compared with sham control, SCI causes increased apoptotic cell death in the peri-injury site (Fig. 5A2) . These results suggest a significant correlation of increased ASIC1a activity with apoptotic cell death in spinal cord injury.
To determine whether increased ASIC1a activity contributed to SCI-induced cell death, we treated the SCI animal with intrathecal injection of ASIC1a antagonists and antisense (AS, targeting to the 5' part of the coding sequence of ASIC 1a). As shown in Figure 5 (B1) and (B2), PcTx1 venom (10 μL, 0.5 mg/ml total protein, ∼25 μg/kg) and amiloride (10 μL, 53.2 μg/mL, ∼0.5 μg/kg) reduced TUNELpositive cells in the areas close to the injury site, and the downregulation of ASIC1a expression by antisense injection decreased the number of TUNEL-positive cells after injury ( Fig. 5B1 and B2) . Images for IS and amiloride treatment groups are not shown. B2, Histogram summarizing the number of TUNEL-positive cells in rats treated with saline control, AS, IS, PcTx1 venom, and Amiloride at 24 hours after injury. Quantification was performed from 9 sections of 3 rats per group, and was analyzed in 5 regions for each section. Values (mean ± SE) were normalized to the saline control, *P < 0.05, compared with saline control (by ANOVA with Fisher's PLSD). Scale bars: without Inset panels, 100 μm, Inset panels, 50 μm; B1, 100 μm.
Furthermore, we observed spinal cord damage in transverse sections after delivery of ASIC1a antagonists or antisense by labeling of neuronal marker NeuN. As shown in Figure 6 and Supplemental Digital Content 2 (available at: http://links.lww.com/SLA/A143), treatment with either ASIC1a antagonists PcTx1 venom, amiloride or ASIC1a antisense reduced the size of tissue damage and prevented the decrease of NeuN-positive cells after SCI, compared with salinecontrol. These results provide direct evidence that suppression of ASIC1a confers neuroprotection, suggesting that increased activity of ASIC1a contributes to SCI-induced cell death and tissue damage.
To provide further evidence for the involvement of ASIC1a in spinal neuronal death, we tested whether acidosis was sufficient to induce spinal neuronal death via ASIC1a. Alive/dead staining with flurorescein diacetate (FDA, green) and propidium iodide (PI, red) showed marked increase of cell death by 1 hour acid (pH 6.0) incubation in cultured spinal neurons (Fig. 7A ). Treatment with ASIC1a antagonist PcTx1 venom significantly attenuated acid-induced neuronal death ( Fig. 7A and B) . Moreover, cotreatment of acid with NaCN largely exacerbated acid-induced neuronal death and PcTx1 venom exerted similar inhibitory role ( Fig. 7A and B) . Collectively, these data suggest that increased activity of ASIC1a by secondary injury-induced acidosis may play a crucial role in mediating neuronal death after SCI.
Suppressing ASIC1a Promotes Functional Recovery After SCI
To examine whether inhibition or down-regulation of ASIC1a could promote the recovery of neurological function in the animal model of weight-drop SCI, we first investigated the effect of PcTx1 venom and amiloride on hindlimb locomotor deficits in injured animals by the test of Basso-Beattie-Bresnahan (BBB) rating scale. 39 The locomotor function was lost immediately after injury, and no obvious recovery was observed up to 3 days after SCI (Fig. 8A) . Compared with control rats injected with saline, intrathecal injection of PcTx1 venom (10 μl, 0.5 mg/ml total protein, ∼25 μg/kg; twice daily) or amiloride (10 μL, 53.2 μg/mL, ∼0.5 μg/kg; twice daily) increased the locomotor score 3 days after injury (Fig. 8A ). Furthermore, intrathecal injection of specific anitsense oligonucleotide (AS) targeting to ASIC1a decreased ASIC1a expression ( Fig. 8C and D) and enhanced the locomotor recovery of SCI rats (Fig. 8B) . These results suggest that suppressing ASIC1a may be a potentially therapeutic strategy for SCI treatment.
DISCUSSION
In this study, we demonstrated that the expression and function of ASIC1a were markedly increased in the injured spinal neurons after SCI. Importantly, suppressing ASIC1a in vivo was shown to markedly attenuate spinal cell damage and promoted functional recovery of injured animals. Thus, this study reveals a mechanism underlying spinal cord secondary injury by which ASIC1a mediates acidotoxic cell death after SCI.
In the CNS, a stable extracellular and intracellular pH is important to maintain normal cellular function. In physiological conditions, extracellular pH is maintained at ∼7.3 whereas intracellular pH is at ∼7.0 through various H + transporting mechanisms. 43, 44 The pH range of spinal cord interstitial fluid under physiological conditions is more acidic than cerebrospinal fluid (7.35-7.40) , with a pH of 7.10-7.35, and pH in the dorsal spinal cord (7.10-7.20) is slightly more acidic than ventral spinal cord (7.25-7.35 ). 45, 46 However, the role of pH in spinal cord under pathological conditions, including SCI, remains unclear.
Increasing evidence suggests that falling pH may play a significant role in spinal cord after traumatic injury. 8, 13, 14, 16, [47] [48] [49] Acidosis is shown to be induced by progressive ischemia or anoxia and the pH value is decreased by approximately 0.6 to 0.8 pH unit in the ischemic spinal cord. 49 As ischemia/anoxia occurring immediately after primary insults is a critical secondary injury event that influences the outcome of SCI, ischemia/hyoxia-induced acidosis may contribute to the secondary damage after SCI. In support of this hypothesis, our data showed that the increase of spinal neuron death caused by NaCN-induced anoxia was attenuated by the blockade of ASIC1a function. Recent studies indicate that acidosis is also induced in injured spinal cord through other secondary injury mechanisms: (1) accumulation of lactic acid, due to enhanced anaerobic glucose metabolism, triggers tissue acidosis 8,18,48 ; (2) excess release of glutamate and ATP induces H + accumulation at the injury site and peri-injury regions after SCI 14, 16, 47 ; and (3) inflammation, a crucial episode after SCI, 18 lowers pH value in the injured spinal cord. Taken together, these findings supports the notion that acidosis is involved in secondary injury-mediated spinal cell death after SCI.
Our study showed that ASIC1a expression was dramatically increased in the peri-injury regions after SCI. Interestingly, this is opposite to ischemic stroke-induced brain injury, in which ASIC1a expression was not significantly altered. 26 Thus, in different neurons ASIC1a may respond to different insults in a distinct manner to participate in the injured process. Of note, our data indicate that the ASIC1a expression is increased in the ventral horn (Fig. 2B1) , a key component controlling voluntary movement of body and limbs. This is consistent with previous findings that the ventral horn motor neurons are selectively degenerated in a variety of spinal cord diseases including amyotrophic lateral sclerosis (ALS) and SCI. [50] [51] [52] Excitotoxicity induced by excessive glutamate has been proposed to contribute to the death of ventral horn neurons, 15, 47, 50 but clinical trials with the use of glutamate receptor antagonists failed to demonstrate efficacy. 6, 53, 54 Because the neuroprotective effect of ASIC1a blockade is not mediated through inhibition of glutamate-induced excitotoxicity, suppressing ASIC1a may offer a new therapeutic strategy for SCI.
The critical evidence obtained in this study is that suppressing ASIC1a not only protected against spinal cell death but also promoted functional recovery of injured animals. Importantly, this study pro-vides direct evidence that amiloride, widely used as diuretics in clinic, promotes the recovery of injured spinal cord in vivo. Thus, amiloride may be potentially used as a therapeutic agent for the treatment of SCI patients.
In conclusion, the study demonstrates for the first time that ASIC1a increased activity contributes to delayed cell death in injured spinal cord induced by the secondary damage of SCI. Suppressing ASIC1a attenuated the death of spinal cells and promotes the recovery of neurological function in SCI animals. Our results provide direct evidence suggesting that ASIC1a may be a potential therapeutic target for the development of novel strategy for the treatment of SCI patient.
